EU data protection regulation—harming cancer research

Risks of the new EU Data protection regulation: an ESMO position paper endorsed by the European oncology community

(2014) P. G. Casali et al.   ANNALS OF ONCOLOGY

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

(2014) Dan Rosmarin et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

(2013) Roberta De Angelis et al.   LANCET ONCOLOGY

Investment biobanking—increased returns from tissue samples

(2013) Valerie Speirs et al.   Nature Reviews Clinical Oncology

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

(2012) Claire Palles et al.   NATURE GENETICS

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

(2011) Richard G. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

(2011) Gordon Hutchins et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

(2010) Ramon Salazar et al.   JOURNAL OF CLINICAL ONCOLOGY